Cargando…

Is CDK9 a promising target for both primary and metastatic osteosarcoma?

Detalles Bibliográficos
Autor principal: Qin, Jiang-Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413331/
https://www.ncbi.nlm.nih.gov/pubmed/30651218
http://dx.doi.org/10.1016/j.ebiom.2019.01.016
_version_ 1783402795310776320
author Qin, Jiang-Jiang
author_facet Qin, Jiang-Jiang
author_sort Qin, Jiang-Jiang
collection PubMed
description
format Online
Article
Text
id pubmed-6413331
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-64133312019-03-21 Is CDK9 a promising target for both primary and metastatic osteosarcoma? Qin, Jiang-Jiang EBioMedicine Commentary Elsevier 2019-01-14 /pmc/articles/PMC6413331/ /pubmed/30651218 http://dx.doi.org/10.1016/j.ebiom.2019.01.016 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Qin, Jiang-Jiang
Is CDK9 a promising target for both primary and metastatic osteosarcoma?
title Is CDK9 a promising target for both primary and metastatic osteosarcoma?
title_full Is CDK9 a promising target for both primary and metastatic osteosarcoma?
title_fullStr Is CDK9 a promising target for both primary and metastatic osteosarcoma?
title_full_unstemmed Is CDK9 a promising target for both primary and metastatic osteosarcoma?
title_short Is CDK9 a promising target for both primary and metastatic osteosarcoma?
title_sort is cdk9 a promising target for both primary and metastatic osteosarcoma?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413331/
https://www.ncbi.nlm.nih.gov/pubmed/30651218
http://dx.doi.org/10.1016/j.ebiom.2019.01.016
work_keys_str_mv AT qinjiangjiang iscdk9apromisingtargetforbothprimaryandmetastaticosteosarcoma